{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:32:36Z","timestamp":1791300756442,"version":"4.1.0"},"reference-count":68,"publisher":"Europa Digital & Publishing","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.4244\/eij-d-16-00471","type":"journal-article","created":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T09:14:59Z","timestamp":1487582099000},"page":"1747-1756","source":"Crossref","is-referenced-by-count":112,"title":["Possible mechanical causes of scaffold thrombosis: insights from case reports with intracoronary imaging"],"prefix":"10.4244","volume":"12","author":[{"given":"Yohei","family":"Sotomi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pannipa","family":"Suwannasom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Serruys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Onuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2774","reference":[{"key":"key-20172420144-0","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.jacc.2008.07.006","article-title":"Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study.","volume":"52","author":"Wenaweser P.","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"key-20172420144-1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.","volume":"48","author":"Joner M.","year":"2006","journal-title":"J Am Coll Cardiol."},{"key":"key-20172420144-2","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.jacc.2011.06.049","article-title":"Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials.","volume":"58","author":"Baber U.","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"key-20172420144-3","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.4244\/EIJY14M07_11","article-title":"Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry.","volume":"10","author":"Capodanno D.","year":"2015","journal-title":"EuroIntervention."},{"key":"key-20172420144-4","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/j.jacc.2015.09.054","article-title":"Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China Trial.","volume":"66","author":"Gao R.","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"key-20172420144-5","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1093\/eurheartj\/ehv435","article-title":"A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan.","volume":"36","author":"Kimura T.","year":"2015","journal-title":"Eur Heart J."},{"key":"key-20172420144-6","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.4244\/EIJY14M08_08","article-title":"Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry.","volume":"10","author":"Kraak RP.","year":"2015","journal-title":"EuroIntervention."},{"key":"key-20172420144-7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jcin.2014.10.005","article-title":"Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).","volume":"8","author":"Brugaletta S.","year":"2015","journal-title":"JACC Cardiovasc Interv."},{"key":"key-20172420144-8","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/S0140-6736(15)01039-9","article-title":"1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis.","volume":"387","author":"Stone GW.","year":"2016","journal-title":"Lancet."},{"key":"key-20172420144-9","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1161\/CIRCULATIONAHA.108.842757","article-title":"Early stent thrombosis: past, present, and future.","volume":"119","author":"Cook S.","year":"2009","journal-title":"Circulation."},{"key":"key-20172420144-10","doi-asserted-by":"publisher","first-page":"600","DOI":"10.4244\/EIJV10I5A103","article-title":"Acute Absorb bioresorbable vascular scaffold thrombosis in ST-segment elevation myocardial infarction: to stent or not to stent?","volume":"10","author":"Fernandez-Rodriguez D.","year":"2014","journal-title":"EuroIntervention."},{"key":"key-20172420144-11","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1093\/eurheartj\/eht060","article-title":"Acute thrombosis of bioabsorbable scaffold in a patient with acute coronary syndrome.","volume":"34","author":"Jaguszewski M.","year":"2013","journal-title":"Eur Heart J."},{"key":"key-20172420144-12","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1093\/eurheartj\/ehu031","article-title":"Very late bioresorbable scaffold thrombosis after discontinuation of dual antiplatelet therapy.","volume":"35","author":"Karanasos A.","year":"2014","journal-title":"Eur Heart J."},{"key":"key-20172420144-13","article-title":"Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: single-center experience.","volume":"8(5)","author":"Karanasos A.","year":"2015","journal-title":"Circ Cardiovasc Interv."},{"key":"key-20172420144-14","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1016\/j.ijcard.2014.04.108","article-title":"Acute stent thrombosis of a bioresorbable vascular scaffold implanted for ST-segment elevation myocardial infarction.","volume":"174","author":"Miyazaki T.","year":"2014","journal-title":"Int J Cardiol."},{"key":"key-20172420144-15","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.ijcard.2014.11.008","article-title":"Pitfalls of bioresorbable vascular scaffold thrombosis--be sure to cover it all.","volume":"177","author":"Abu Sharar H.","year":"2014","journal-title":"Int J Cardiol."},{"key":"key-20172420144-16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4244\/EIJV10I4A78","article-title":"Lessons learned from acute and late scaffold failures in the ABSORB EXTEND trial.","volume":"10","author":"Ishibashi Y.","year":"2014","journal-title":"EuroIntervention."},{"key":"key-20172420144-17","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.jacc.2015.08.853","article-title":"Very Late Scaffold Thrombosis: Intracoronary Imaging and Histopathological and Spectroscopic Findings.","volume":"66","author":"Raber L.","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"key-20172420144-18","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/j.ijcard.2014.04.116","article-title":"The pitfalls of managing thrombosis of an Absorb\u2122-treated bifurcation.","volume":"174","author":"Schiattarella GG.","year":"2014","journal-title":"Int J Cardiol."},{"key":"key-20172420144-19","article-title":"30-days follow up of the German-Austrian-ABSORB Register: GABI-R (abstract).","author":"Hamm C.","year":"2015","journal-title":"Presented at: EuroPCR. Paris, France"},{"key":"key-20172420144-20","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.4244\/EIJV11I1A14","article-title":"Very late bioresorbable vascular scaffold thrombosis: a new clinical entity.","volume":"11","author":"Azzalini L.","year":"2015","journal-title":"EuroIntervention."},{"key":"key-20172420144-21","first-page":"85","article-title":"Bioresorbable vascular scaffold thrombosis in an all-comer patient population: single-center experience.","volume":"27","author":"Azzalini L.","year":"2015","journal-title":"J Invasive Cardiol."},{"key":"key-20172420144-22","article-title":"The 2-year clinical outcomes of the ABSORB II trial: first randomized comparison between the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE everolimus-eluting stent.","author":"Chevalier B.","year":"2015","journal-title":"Transcatheter Cardiovascular Therapeutics (TCT). San Francisco, CA, USA"},{"key":"key-20172420144-23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ijcard.2015.04.018","article-title":"Very late bioresorbable vascular scaffold thrombosis due to late device recoil.","volume":"189","author":"Cortese B.","year":"2015","journal-title":"Int J Cardiol."},{"key":"key-20172420144-24","doi-asserted-by":"crossref","first-page":"e002518","DOI":"10.1161\/CIRCINTERVENTIONS.114.002518","article-title":"Optical Coherence Tomography Findings in Bioresorbable Vascular Scaffolds Thrombosis.","volume":"8","author":"Cuculi F.","year":"2015","journal-title":"Circ Cardiovasc Interv."},{"key":"key-20172420144-25","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00380-014-0513-8","article-title":"Subacute bioresorbable vascular scaffold thrombosis: a report of 2 cases.","volume":"30","author":"Ho HH.","year":"2015","journal-title":"Heart Vessels."},{"key":"key-20172420144-26","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1016\/j.jcin.2015.03.035","article-title":"Late Structural Discontinuity as a Possible Cause of Very Late Everolimus-Eluting Bioresorbable Scaffold Thrombosis.","volume":"8","author":"Ielasi A.","year":"2015","journal-title":"JACC Cardiovasc Interv."},{"key":"key-20172420144-27","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/j.jcin.2015.06.026","article-title":"Very Late Scaffold Thrombosis Due to Insufficient Strut Apposition.","volume":"8","author":"Meincke F.","year":"2015","journal-title":"JACC Cardiovasc Interv."},{"key":"key-20172420144-28","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/eurheartj\/ehu419","article-title":"Very late bioresorbable vascular scaffold thrombosis following discontinuation of antiplatelet therapy.","volume":"36","author":"Timmers L.","year":"2015","journal-title":"Eur Heart J."},{"key":"key-20172420144-29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s12928-015-0364-y","article-title":"Very late scaffold thrombosis of everolimus-eluting bioresorbable scaffold following implantation in STEMI after discontinuation of dual antiplatelet therapy.","volume":"32","author":"Yahagi K.","year":"2017","journal-title":"Cardiovasc Interv Ther."},{"key":"key-20172420144-30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/eurheartj\/ehv500","article-title":"Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.","volume":"37","author":"Sabat\u00e9 M.","year":"2016","journal-title":"Eur Heart J."},{"key":"key-20172420144-31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1161\/CIRCINTERVENTIONS.113.000931","article-title":"Incomplete stent apposition causes high shear flow disturbances and delay in neointimal coverage as a function of strut to wall detachment distance: implications for the management of incomplete stent apposition.","volume":"7","author":"Foin N.","year":"2014","journal-title":"Circ Cardiovasc Interv."},{"key":"key-20172420144-32","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.jacc.2015.12.019","article-title":"Bioresorbable Coronary Scaffold Thrombosis: Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and Predictors.","volume":"67","author":"Puricel S.","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"key-20172420144-33","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.jcin.2015.07.026","article-title":"Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II).","volume":"8","author":"Ishibashi Y.","year":"2015","journal-title":"JACC Cardiovasc Interv."},{"key":"key-20172420144-34","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.jcin.2014.06.016","article-title":"Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).","volume":"7","author":"Onuma Y.","year":"2014","journal-title":"JACC Cardiovasc Interv."},{"key":"key-20172420144-35","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/MCA.0000000000000134","article-title":"Peri-strut low-intensity areas in optical coherence tomography correlate with peri-strut inflammation and neointimal proliferation: an in-vivo correlation study in the familial hypercholesterolemic coronary swine model of in-stent restenosis.","volume":"25","author":"Tellez A.","year":"2014","journal-title":"Coron Artery Dis."},{"key":"key-20172420144-36","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1161\/CIRCINTERVENTIONS.113.000990","article-title":"Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium XIENCE V stent in a porcine coronary artery model.","volume":"7","author":"Otsuka F.","year":"2014","journal-title":"Circ Cardiovasc Interv."},{"key":"key-20172420144-37","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.jcin.2011.08.016","article-title":"Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.","volume":"4","author":"Gomez-Lara J.","year":"2011","journal-title":"JACC Cardiovasc Interv."},{"key":"key-20172420144-38","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/01.CIR.93.7.1354","article-title":"Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death.","volume":"93","author":"Farb A.","year":"1996","journal-title":"Circulation."},{"key":"key-20172420144-39","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.jacc.2011.10.903","article-title":"Role of endothelial shear stress in stent restenosis and thrombosis: pathophysiologic mechanisms and implications for clinical translation.","volume":"59","author":"Koskinas KC.","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"key-20172420144-40","doi-asserted-by":"publisher","first-page":"e002427","DOI":"10.1161\/CIRCINTERVENTIONS.115.002427","article-title":"Thrombogenicity and early vascular healing response in metallic biodegradable polymer-based and fully bioabsorbable drug-eluting stents.","volume":"8","author":"Koppara T.","year":"2015","journal-title":"Circ Cardiovasc Interv."},{"key":"key-20172420144-41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres.","volume":"28","author":"Shive MS.","year":"1997","journal-title":"Adv Drug Deliv Rev."},{"key":"key-20172420144-42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4244\/EIJY15M01_05","article-title":"Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective.","volume":"11","author":"Tamburino C.","year":"2015","journal-title":"EuroIntervention."},{"key":"key-20172420144-43","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jcin.2014.11.014","article-title":"Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffold.","volume":"8","author":"Mangiameli A.","year":"2015","journal-title":"JACC Cardiovasc Interv."},{"key":"key-20172420144-44","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jacc.2014.12.017","article-title":"Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.","volume":"65","author":"Puricel S.","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"key-20172420144-45","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","article-title":"Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.","volume":"373","author":"Ellis SG.","year":"2015","journal-title":"N Engl J Med."},{"key":"key-20172420144-46","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.jacc.2015.11.060","article-title":"A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-Up.","volume":"67","author":"Serruys PW.","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"key-20172420144-47","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.jcin.2013.05.017","article-title":"Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.","volume":"6","author":"Onuma Y.","year":"2013","journal-title":"JACC Cardiovasc Interv."},{"key":"key-20172420144-48","doi-asserted-by":"crossref","first-page":"669","DOI":"10.20452\/pamw.2550","article-title":"Bioresorbable vascular scaffolds in patients with acute coronary syndromes: the POLAR ACS study.","volume":"124","author":"Dudek D.","year":"2014","journal-title":"Pol Arch Med Wewn."},{"key":"key-20172420144-49","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.4244\/EIJV9I9A176","article-title":"Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes.","volume":"9","author":"Gori T.","year":"2014","journal-title":"EuroIntervention."},{"key":"key-20172420144-50","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/eurheartj\/eht545","article-title":"Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study \u2018Prague 19\u2019.","volume":"35","author":"Koka V.","year":"2014","journal-title":"Eur Heart J."},{"key":"key-20172420144-51","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/eurheartj\/eht546","article-title":"Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study.","volume":"35","author":"Diletti R.","year":"2014","journal-title":"Eur Heart J."},{"key":"key-20172420144-52","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00392-013-0630-x","article-title":"Short-term outcome of patients with ST-segment elevation myocardial infarction (STEMI) treated with an everolimus-eluting bioresorbable vascular scaffold.","volume":"103","author":"Wiebe J.","year":"2014","journal-title":"Clin Res Cardiol."},{"key":"key-20172420144-53","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.amjcard.2015.05.049","article-title":"Clinical Comparison With Short-Term Follow-Up of Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Stent in Primary Percutaneous Coronary Interventions.","volume":"116","author":"Cortese B.","year":"2015","journal-title":"Am J Cardiol."},{"key":"key-20172420144-54","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4244\/EIJY14M10_11","article-title":"Immediate and midterm outcomes following primary PCI with bioresorbable vascular scaffold implantation in patients with ST-segment myocardial infarction: insights from the multicentre \u201cRegistro ABSORB Italiano\u201d (RAI registry).","volume":"11","author":"Ielasi A.","year":"2015","journal-title":"EuroIntervention."},{"key":"key-20172420144-55","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.4244\/EIJV10I12A243","article-title":"The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled.","volume":"10","author":"Abizaid A.","year":"2015","journal-title":"EuroIntervention."},{"key":"key-20172420144-56","article-title":"TCT-527 Long-term Clinical Outcomes of Patients Treated With The Everolimus-eluting Bioresorbable Vascular Scaffold. The BVS Expand Study.","volume":"66(15_S)","author":"Felix C.","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"key-20172420144-57","first-page":"316","article-title":"Twelve-Month Outcomes With a Bioresorbable Everolimus-Eluting Scaffold: Results of the ESHC-BVS Registry at Two Australian Centers.","volume":"28","author":"Robaei D.","year":"2016","journal-title":"J Invasive Cardiol."},{"key":"key-20172420144-58","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s00392-014-0757-4","article-title":"Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios.","volume":"104","author":"Jaguszewski M.","year":"2015","journal-title":"Clin Res Cardiol."},{"key":"key-20172420144-59","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.1002\/ccd.25569","article-title":"Comparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population.","volume":"85","author":"Costopoulos C.","year":"2015","journal-title":"Catheter Cardiovasc Interv."},{"key":"key-20172420144-60","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.carrev.2015.09.002","article-title":"Evaluation of the short- and long-term safety and therapy outcomes of the everolimus-eluting bioresorbable vascular scaffold system in patients with coronary artery stenosis: Rationale and design of the German-Austrian ABSORB RegIstRy (GABI-R).","volume":"17","author":"Nef H.","year":"2016","journal-title":"Cardiovasc Revasc Med."},{"key":"key-20172420144-61","article-title":"TCT-544 Bioresorbable Coronary Devices in Clinical Practice: Immediate and 30-day Results of the Prospective REPARA Registry.","volume":"66(15_S)","author":"Hernandez F.","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"key-20172420144-62","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jcin.2014.01.155","article-title":"1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.","volume":"7","author":"Muramatsu T.","year":"2014","journal-title":"JACC Cardiovasc Interv."},{"key":"key-20172420144-63","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4244\/EIJY14M12_10","article-title":"Beyond the early stages: insights from the ASSURE registry on bioresorbable vascular scaffolds.","volume":"11","author":"W\u00f6hrle J.","year":"2015","journal-title":"EuroIntervention."},{"key":"key-20172420144-64","doi-asserted-by":"publisher","first-page":"555","DOI":"10.4244\/EIJY14M12_07","article-title":"Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study.","volume":"11","author":"Vaquerizo B.","year":"2015","journal-title":"EuroIntervention."},{"key":"key-20172420144-65","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ijcard.2015.07.002","article-title":"Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: results from a multicenter Italian experience.","volume":"199","author":"Moscarella E.","year":"2015","journal-title":"Int J Cardiol."},{"key":"key-20172420144-66","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ijcard.2014.03.061","article-title":"Early results following everolimus-eluting bioresorbable vascular scaffold implantation for the treatment of in-stent restenosis.","volume":"173","author":"Ielasi A.","year":"2014","journal-title":"Int J Cardiol."},{"key":"key-20172420144-67","first-page":"554","article-title":"Bioresorbable Vascular Scaffold for the Treatment of Coronary Bifurcation Lesions: Immediate Results and 1-year Follow-up.","volume":"69","author":"Su\u00e1rez de Lezo J.","year":"2016","journal-title":"Rev Esp Cardiol (Engl Ed)."}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T14:22:17Z","timestamp":1749997337000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/114th_issue\/285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":68,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["EIJ-D-16-00471"],"URL":"https:\/\/doi.org\/10.4244\/eij-d-16-00471","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}